SINGAPORE (July 9): Since its IPO in May last year, Hyphens Pharma International, the specialty pharmaceutical and consumer healthcare group, has gradually been building up its presence, both locally and in the region.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply